trial · primary record
Pazopanib
Hereditary Hemorrhagic Telangiectasia
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 71 |
| Primary completion | 2026-08-26 |
| Primary endpoint | Change in epistaxis duration in minutes |
| Registry ID | NCT03850964 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:33.588Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03850964
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.